Copyright
©2014 Baishideng Publishing Group Co.
World J Clin Oncol. Feb 10, 2014; 5(1): 1-18
Published online Feb 10, 2014. doi: 10.5306/wjco.v5.i1.1
Published online Feb 10, 2014. doi: 10.5306/wjco.v5.i1.1
Ref. | Year | Technique | n | Tumor size (cm) | Follow-up (mo) | Local recurrence (%) | Patient satisfaction (%) |
Papp et al[12] | 1998 | Superior pedicle | 10 | NR | 52 | 5 | 95 |
Nos et al[71] | 1998 | Superior pedicle | 50 | 3.25 | 48 | 7 | 85 |
Spear et al[18] | 2003 | Superior pedicle | 56 | NR | 46 | 6.9 | 91 |
Clough et al[41] | 2003 | Superior pedicle | 101 | 3.2 | 24 | 0 | 88 |
Chang et al[19] | 2004 | Superior pedicle | 37 | 0.6-5.2 | NR | 0 | NR |
Goffman et al[74] | 2005 | Superior pedicle | 57 | NR | 18 | 13 | 82 |
Munhoz et al[15] | 2006 | Superior pedicle | 74 | 2-4.0 | 22 | 0 | 93 |
Munhoz et al[16] | 2006 | Superior-medial pedicle | 39 | 2-4.0 | 20 | 0 | 90 |
Munhoz et al[17] | 2007 | Inferior pedicle | 26 | 2-4.0 | 21 | 0 | 89 |
Fitoussi et al[47] | 2010 | Superior pedicle | 540 | 2.9 | 49 | 6.8 | 90 |
Ref. | Year | n | Tumor size (cm) | Adjuvant chemotherapy n (%) | Delay in chemotherapy | Delayed adjuvant chemotherapy n (%) |
Nos et al[71] | 1998 | 50 | Tis-T4 | 5 (10) | + | 3 (6) |
Losken et al[23] | 2002 | 20 | Tis-N/D | N/D | - | 0 |
Clough et al[41] | 2003 | 101 | T1-T4 | 0 | + | 4 (4) |
Spear et al[18] | 2003 | 22 | N/D | 22 (100) | - | 0 |
McCulley et al[53] | 2005 | 50 | Tis-N/D | 23 (46) | - | 0 |
Munhoz et al[15] | 2006 | 74 | T1-T2 | 22 (29.7) | - | 0 |
Thornton et al[54] | 2006 | 6 | T1-T2 | 0 | - | 0 |
Kronowitz et al[50] | 2007 | 41 | Tis-T2 | 18 (44) | - | 0 |
Losken et al[25] | 2007 | 63 | Tis-N/D | N/D | - | 0 |
Rietjens et al[42] | 2007 | 148 | T1-T3 | 89 (60) | - | 0 |
Meretoja et al[72] | 2010 | 90 | Tis-T3 | 60 (67) | + | 2 (2) |
Fitoussi et al[47] | 2010 | 540 | T1-T3 | N/D | + | 10 (1.9) |
Song et al[55] | 2010 | 28 | Tis | N/A | - | 0 |
Romics et al[56] | 2012 | 31 | T1-T3 | 31 (100) | - | 0 |
Kahn et al[28] | 2013 | 169 | T1-T3 | N/D | - | 0 |
Ref. | n | Follow-up (mo) | Tumor size (cm) | Positive margins (%) | Local recurrence (%) |
Clough et al[41] 2003 | 101 | 46 | 3.2 (0.1-7) | 10.9 | 6.9 |
Clough et al[7] 1999 | 20 | 54 | NS | 0 | 5 |
Nos et al[71] 1998 | 50 | 48 | 3.5 (1.5-6) | 10 | 7 |
Papp et al[12] 1998 | 10 | 52 | NS | 0 | 5 |
Masetti et al[75] 2000 | 56 | 23 | NS | NS | 0 |
Spear et al[18] 2003 | 11 | 24 | NS | 0 | 0 |
Chang et al[19] 2004 | 37 | NS | 0.6-5.2 | 2.7 | 0 |
Losken et al[23] 2002 | 14 | 23 | 1.5 (0.6-3) | 28.6 | 0 |
Munhoz et al[15] 2006 | 74 | 22 | 1.9 (0.6-3.9) | 9.5 | 0 |
Fitoussi et al[47] 2010 | 540 | 49 | 2.9 | 5 | 6.8 |
- Citation: Munhoz AM, Montag E, Gemperli R. Current aspects of therapeutic reduction mammaplasty for immediate early breast cancer management: An update. World J Clin Oncol 2014; 5(1): 1-18
- URL: https://www.wjgnet.com/2218-4333/full/v5/i1/1.htm
- DOI: https://dx.doi.org/10.5306/wjco.v5.i1.1